Home › NDC Lookup › Ingredients › Benzoyl Peroxide › 00536-1055-56
Rugby Benzoyl Peroxide Acne Medication 50 mg/mL Gel, 1 tube — NDC 00536-1055-56 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Rugby Benzoyl Peroxide Acne Medication 50 mg/mL Gel, 1 tube — NDC 0536-1055-56 (Billing 00536-1055-56)

by Rugby Laboratories · 1 TUBE in 1 CARTON / 42.5 mL in 1 TUBE

This is a package of 1 tube of Rugby Benzoyl Peroxide Acne Medication 50 mg/mL Gel from Rugby Laboratories, marketed since Jan 2015 and currently FDA-listed; retail pharmacies pay about $0.0839 per g (NADAC). It is the main listing for this product, which comes in 3 package sizes.

NDC 00536-1055-56
🏷️ FDA NDC (as labeled) 0536-1055-56 billing pads the labeler segment with a zero
This package
Contains1 tube Cost per g$0.0839 NADAC Pack sizes3 compare ↓
Also priced by: Medicaid pays $0.2230/unit — full pricing hub ↓
Main listing for product 0536-1055 · Also comes in: 60 mL 0536-1055-25 90 mL 0536-1055-57
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 0536-1055-56 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0536 labeler · 1055 product · 56 package
Package marketed since
Jan 20, 2015
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 0536105556 1
Medicaid fills, this package
35,449 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Benzoyl Peroxide (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Feb 24, 2025 — Chemical Contamination: Presence of benzene. (Denison Pharmaceuticals, LLC) · FDA recall D-0273-2025
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0536-1055-56
Product NDC 0536-1055
11-digit billing NDC 00536105556
NCPDP billing unit GM — per gram (weight)
RxCUI 308694
UNII W9WZN9A0GM
Application # M006
SPL Set ID de9ac9fe-b6af-45b7-bbf2-70c47f45885b
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2015-01-20
Route TOPICAL
Dosage form GEL
Substance BENZOYL PEROXIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90050010004010
GPI class Acne Medication 5
GCN Seq No 005813
GCN 22931
HICL code 002470
Ingredient (HICL) Benzoyl Peroxide
HIC1 code L
Therapeutic class — broad (HIC1) Skin/Subcutaneous Tissue
HIC2 code L5
Therapeutic class — intermediate (HIC2) Keratolytics/Keratoplastics
HIC3 code L5A
Therapeutic class — specific (HIC3) Keratolytics
AHFS code 84:28.00.00
AHFS class Keratolytic Agents
FDB label name ACNE MEDICATION 5% GEL
FDB brand name Acne Medication
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 005813
  • GCN: 22931
  • GPI-14 (Medi-Span): 90050010004010
  • HICL (First Databank): 002470
  • AHFS class code: 84:28.00.00
  • RxCUI (RxNorm): 308694
Why two NDCs? The FDA registers this code as 0536-1055-56 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00536-1055-56. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Peroxides class.

Drug family (ATC) Peroxides
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name ACNE MEDICATION 5% GEL Ingredient Benzoyl Peroxide
📗 Our plain-language guide HelloPharmacist
  • Most products are for acne. They dry up pimples and help prevent new ones. Epsolay is a prescription cream for rosacea bumps in adults. The Folliculitis Treatment Cream products ar...
  • For many acne products, start with once a day. You can move up to two or three times daily if your skin tolerates it. If you get dryness or peeling, cut back to once daily or every...
  • Redness, dryness, peeling, itching, and stinging or burning are the usual ones. Using less often can help. Using another acne product at the same time makes irritation more likely.
  • Stop if irritation gets severe. Stop right away and get help if you have hives, swelling or trouble breathing. Those can be signs of a serious allergic reaction.
📖 Read our full Benzoyl Peroxide guide →

Supplement & herbal interactions

Some supplements/herbs that may interact with Benzoyl Peroxide — tap one for details:

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $0.084 —
Medicaid paysCMS SDUD · 12 mo $0.2230 —
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Dec 2021 Jul 2022 Feb 2024 Sep 2026 $0.086 $0.053
▲ Up 6% over the last 23 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
00536-1055-25 0536-1055-25 1 TUBE in 1 CARTON / 60 mL in 1 TUBE $0.2175 / g — 2019-10-31 Feb 1, 2027 Active
00536-1055-56 You're viewing this Main listing 1 TUBE in 1 CARTON / 42.5 mL in 1 TUBE $0.0839 / g — 2015-01-20 — Active
00536-1055-57 0536-1055-57 1 TUBE in 1 CARTON / 90 mL in 1 TUBE — — 2019-10-31 — Discontinued by firm

This pack has the lowest per-g cost of the 2 priced pack sizes ($0.0839 NADAC).

In Medicaid, this is the most-dispensed pack of this product — about 92% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This package contains 1 tube — 1 tube in 1 carton / 42.5 ml in 1 tube.
What NDC number is used to bill for this package of Rugby Benzoyl Peroxide Acne Medication 50 mg/mL Gel?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Rugby Benzoyl Peroxide Wash Acne Medication 50 mg/mL 00536-1259-19 Rugby 236 ml $0.028 — Availability likely save 66%
Rugby Benzoyl Peroxide Acne Medication 50 mg/mL 00536-1057-75 Rugby 1 tube $0.067 — Discontinued save 20%
Rugby Benzoyl Peroxide Acne Medication 50 mg/mLthis 00536-1055-56 Rugby 1 tube $0.084 — Availability likely —
benzoyl peroxide 5 g/100g 45802-0216-01 Padagis 1 tube $0.178 — Availability likely +112%
Rugby Benzoyl Peroxide Acne Medication 50 mg/g 00536-1467-25 Rugby 1 tube $0.218 — Availability likely +159%
Rugby Benzoyl Peroxide Acne Medication 50 mg/mL 50090-1720-00 A-S 1 tube — — FDA listed —
Replenix Acne 50 mg/g 51326-0411-57 Topiderm, 57 g — — FDA listed —
Clear Proof Acne Treatment Acne Medication 5 g/100g 51531-9071-00 Mary 3 g — — FDA listed —
Benzoyl Peroxide Acne Medication 50 mg/mL 68071-2307-05 NuCare 42.5 ml — — FDA listed —
5 Acne Med 50 mg/mL 70707-0155-15 Face 1 tube — — Discontinued —
Acne Med 5% 50 mg/mL 70707-0211-15 Face 1 bottle — — FDA listed —
MEDPURA Benzoyl Peroxide Aqueous Base, Acne Treatment Gel 50 mg/mL 71399-9478-05 Akron 1 tube — — FDA listed —
HUMANE Acne Spot Treatment 50 mg/mL 73010-0127-00 Apprendista, 1 tube — — FDA listed —
24 Hour Acne Serum 5 g/100g 83286-0007-01 Drmtlgy, 32 g — — FDA listed —
Glytone Acne BPO Treatment Gel .05 g/g 84262-0030-01 Glytone, 60 g — — FDA listed —
ACNE FORTE Acne Treatment Cream 50 mg/mL 52063-0709-00 GSCM 1 jar — — FDA listed —
SERIOUS SKINCARE Continuously Clear Clearz It 50 mg/mL 53755-0392-00 Flageoli 59 ml — — FDA listed —
Acne Treatment 50 mg/mL 67226-2050-03 Vivier 1 tube — — FDA listed —
MD-Acne Body Acne Treatment 50 mg/mL 71804-0230-06 MD 180 ml — — FDA listed —
Nighttime Control 50 mg/mL 76458-0333-02 Circadia 1 bottle — — FDA listed —
5 Percent Benzoyl Peroxide Cleanser 50 mg/mL 81136-0023-01 Brand 1 tube — — FDA listed —
Walgreens Daily Acne Cleanser- Sensitive Skin Formula 50 mg/mL 00363-5602-01 Walgreen 1 tube — — FDA listed —
MDacne Customized Acne Treatment Benzoyl Peroxide 50 mg/mL 71804-0536-00 MDAlgorithms 1 tube — — FDA listed —
MDacne Body Acne Treatment Benzoyl Peroxide 50 mg/mL 71804-0532-00 MDAlgorithms 90 ml — — FDA listed —
OXY Sensitive Face Wash Maximum Soothing 50 mg/mL 10742-1313-01 The 148 ml — — FDA listed —
Clenziderm Therapeutic 50 mg/mL 62032-0611-01 Obagi 47 ml — — FDA listed —
Face Reality 5% Advanced Acne Med 50 mg/mL 70707-0157-01 Face 1 tube — — FDA listed —
OXY Advanced Care Sensitive Skin Acne Cleanser 50 mg/mL 10742-1203-01 The 148 ml — — FDA listed —
Naturium Benzoyl Peroxide Cleanser 5% 50 mg/mL 76354-0123-01 e.l.f. 1 tube — — FDA listed —
BLAIR and JACK Anti-Bump Acne Treatment 50 mg/mL 84377-0489-00 Blair 1 jar — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2015
On the market since
Jan 2015
📍
2026
Currently FDA-listed
11 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII K679OBS311
    Carboxymethylcellulose sodium is a plant-derived thickening agent made from cellulose. In medicines, it acts as a binder to hold ingredients together, a disintegrant to help the tablet break apart, or a thickener in liquids.
  • UNII 7FLD91C86K
    Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
  • UNII 6HQ855798J
    Laureth-4 is a synthetic detergent made from lauryl alcohol and ethylene oxide. It acts as an emulsifier and solubilizer, helping blend oil and water-based ingredients and improve how the body absorbs the active drug.
  • UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

6 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescarbomer, disodium EDTA, laureth-4, sodium hydroxide, titanium dioxide, water

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerRugby Laboratories
FDA applicationM006 (OTC MONOGRAPH DRUG)
Labeler code00536
First marketedJan 2015
Product typeHuman Otc Drug
Portfolio149 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 6 words ▾

Use for the treatment of acne

⏱️ Dosage and Administration 31 words ▾

Directions Cleanse skin thoroughly before applying medication. Cover the entire affected area with a thin layer 1-3 times daily. If bothersome dryness or peeling occurs, reduce application to once a day.

⚠️ Warnings 174 words ▾

Warnings For external use only Do not use this medication if you have very sensitive skin or if you are sensitive to benzoyl peroxide. When using this product n keep away from eyes, lips and mouth avoid unnecessary sun exposure and use a sunscreen avoid contact with hair or dyed fabric, including carpet and clothing which may be bleached by this product skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Mild irritation may be reduced by using the product less frequently or in a lower concentration.

If irritation becomes severe, discontinue use; if irritation still continues, consult a doctor. using other topical acne medication at the same time or immediately following the use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor. Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away. Avoid contact with the eyes. If contact occurs, flush thoroughly with water.

📦 Storage and Handling 17 words ▾

Other information Keep tightly closed. Avoid storing at extreme temperatures (below 40° F and above 100° F).

🧪 Active Ingredient 8 words ▾

Active ingredient Benzoyl peroxide 5% Purpose Acne treatment

🧪 Inactive Ingredients 11 words ▾

Inactive ingredients carbomer, disodium EDTA, laureth-4, sodium hydroxide, titanium dioxide, water

🎯 Purpose 3 words ▾

Purpose Acne treatment

📄 Do Not Use 19 words ▾

Do not use this medication if you have very sensitive skin or if you are sensitive to benzoyl peroxide.

📄 When Using This Product 119 words ▾

When using this product n keep away from eyes, lips and mouth avoid unnecessary sun exposure and use a sunscreen avoid contact with hair or dyed fabric, including carpet and clothing which may be bleached by this product skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Mild irritation may be reduced by using the product less frequently or in a lower concentration. If irritation becomes severe, discontinue use; if irritation still continues, consult a doctor. using other topical acne medication at the same time or immediately following the use of this product may increase dryness or irritation of the skin.

If this occurs, only one medication should be used unless directed by a doctor.

📄 Keep Out of Reach of Children 31 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. Avoid contact with the eyes. If contact occurs, flush thoroughly with water.

📄 Questions or Comments 4 words ▾

Questions or comments? 1-800-645-2158

📄 Package Label / Principal Display Panel 34 words ▾

PRINCIPAL DISPLAY PANEL - 42.5 g Tube Carton NDC 0536-1055-56 Rugby ® Acne Medication Benzoyl Peroxide Gel USP, 5% 5 Net Wt 1.5 oz (42.5 g) Principal Display Panel - 42.5 g Tube Carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
35.4K
Units reimbursed last 4 qtrs
1.6M
Gross reimbursed last 4 qtrs
$353.8K
Avg / prescription
$9.98
Avg / unit
$0.2230
Latest quarter Q1 2026
1.5KRx
Medicaid pays / g
$0.2230
gross reimbursed
vs
NADAC / g
$0.0839
acquisition cost
=
Spread
+$0.1391
+166% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
61% FFS 39% MCO
Fee-for-service · 21,558 Rx Managed care · 13,891 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 12,161 units · 212 per 100k residents MN Wisconsin: 18,435 units · 312 per 100k residents WI Michigan: 41,159 units · 410 per 100k residents MI New York: 441,855 units · 2,258 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 21,183 units · 500 per 100k residents OR Nevada: 24,438 units · 765 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: 9,945 units · 310 per 100k residents IA Illinois: 7,565 units · 60.3 per 100k residents IL Indiana: 30,218 units · 440 per 100k residents IN Ohio: 67,703 units · 574 per 100k residents OH Pennsylvania: 52,155 units · 402 per 100k residents PA New Jersey: 107,185 units · 1,154 per 100k residents NJ Massachusetts: 42,293 units · 604 per 100k residents MA California: 432,955 units · 1,111 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 2,465 units · 125 per 100k residents NE Missouri: no data reported MO Kentucky: 24,335 units · 538 per 100k residents KY West Virginia: 2,635 units · 149 per 100k residents WV Virginia: 18,190 units · 209 per 100k residents VA Maryland: 44,455 units · 719 per 100k residents MD Connecticut: 12,410 units · 343 per 100k residents CT Rhode Island: 8,840 units · 807 per 100k residents RI Arizona: 5,100 units · 68.6 per 100k residents AZ New Mexico: 3,010 units · 142 per 100k residents NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: 8,925 units · 125 per 100k residents TN North Carolina: no data reported NC South Carolina: 6,545 units · 122 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: 4,691 units · 160 per 100k residents MS Alabama: no data reported AL Georgia: 21,165 units · 192 per 100k residents GA D.C.: 1,250 units · 184 per 100k residents DC Hawaii: 8,415 units · 586 per 100k residents HI Texas: 105,010 units · 344 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
60.32,258
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 2,258 /100k
2 New Jersey 1,154 /100k
3 California 1,111 /100k
4 Rhode Island 807 /100k
5 Nevada 765 /100k
6 Maryland 719 /100k
7 Massachusetts 604 /100k
8 Hawaii 586 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
1 tube this page00536-1055-56 35,449 Rx · $353,761
1 tube00536-1055-25 3,171 Rx · $51,597
1 tube00536-1055-57 No Medicaid data
Drug total (last 4 qtrs): 38,620 Rx · 1,778,668 units · $405,358 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Epsolay (matched by generic name) — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Epsolay. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$60.9K
Claims incl. refills
82
Beneficiaries
63
Spend / beneficiary
$967.04
Spend / claim
$742.97
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.